Description and Brand Names
US Brand Name
- Brineura
Descriptions
Cerliponase alfa injection is used to treat late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) or tripeptidyl peptidase 1 (TPP1) deficiency. It helps slow down the loss of walking ability in children 3 years of age and older.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2019
Copyright © 2019 IBM Watson Health. Todos los derechos reservados. La información es de uso exclusivo para usuarios finales y se prohíbe su venta, redistribución o uso con fines comerciales.